V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001899 | 240008313 | 1.63 | 98 | null | 2018-04-17 | 2018-04-17 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 100190848 |
| 240001903 | 240008316 | null | null | null | null | 2016-08-01 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 100923586 |
| 240001905 | 240008317 | 1.77 | 86.5 | 03 | 2019-04-12 | 2019-05-13 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100784879 |
| 240001909 | 240008318 | 1.84 | 78 | null | 2020-01-18 | 2020-01-18 | Hydroxycarbamide | null | null | HYDROXYCARBAMIDE | 101780842 |
| 240001912 | 240008321 | 1.67 | 83.9 | Curative (C) | null | 2021-06-09 | null | 02 | N | AML19 TRIAL | 100060591 |
| 240001913 | 240008322 | 1.86 | 79.8 | null | 2021-02-04 | 2021-02-04 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100748039 |
| 240001922 | 240008324 | 1.53 | 34.8 | Curative (C) | null | 2019-12-13 | null | 02 | N | METHOTREXATE | 101630483 |
| 240001929 | 240008326 | 1.73 | 71 | 03 | null | 2022-04-15 | null | 02 | N | CHOP R | 100551932 |
| 240001943 | 240008329 | 1.68 | 84 | null | null | 2021-05-24 | null | 02 | null | AML19 TRIAL | 100562552 |
| 240001951 | 240008330 | 1.65 | 33 | null | null | 2021-05-28 | null | 02 | null | AML19 TRIAL | 100267105 |
| 240001952 | 240008331 | 1.8 | 90.4 | null | 2017-02-14 | 2017-04-03 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100052028 |
| 240001953 | 240008332 | null | null | Adjuvant (A) | 2022-03-23 | 2022-03-23 | Hydroxycarbamide | N | N | HYDROXYCARBAMIDE | 100451082 |
| 240001972 | 240008339 | null | null | null | null | 2018-06-06 | null | 02 | null | HYDROXYCARBAMIDE | 100926859 |
| 240001974 | 240008340 | 1.73 | 71.1 | null | null | 2016-04-28 | null | 02 | N | TRIAL UNSPECIFIED | 101470686 |
| 240001977 | 240008341 | 1.78 | 96.7 | null | 2022-01-10 | 2022-01-11 | Hydroxycarbamide | N | null | HYDROXYCARBAMIDE | 100102552 |
| 240001978 | 240008342 | 1.85 | 83.3 | 03 | 2021-08-25 | 2021-08-25 | Rituximab | 02 | null | RITUXIMAB | 100626051 |
| 240001979 | 240008343 | null | null | null | 2020-06-07 | 2020-06-09 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100817622 |
| 240001980 | 240008344 | null | null | null | null | 2018-11-24 | null | 01 | null | AML18 TRIAL | 100601255 |
| 240001998 | 240008347 | null | null | null | null | 2021-08-29 | null | 02 | null | HYDROXYCARBAMIDE | 101132119 |
| 240002000 | 240008349 | 1.93 | 95 | null | null | 2019-11-17 | null | null | N | AML18 TRIAL | 100272729 |
| 240002006 | 240008352 | 1.66 | 70 | 03 | null | 2020-04-09 | null | null | N | BENDAMUSTINE + RITUXIMAB | 101790567 |
| 240002011 | 240008355 | 1.9 | 57.9 | null | null | 2021-10-04 | GEMTUZUMAB OZOGAMICIN | null | null | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 100881926 |
| 240002012 | 240008356 | 1.78 | 53.7 | null | 2018-08-15 | 2018-08-15 | BUSULFAN | 02 | null | BENDAMUSTINE | 100583867 |
| 240002013 | 240008357 | null | null | null | null | 2019-04-11 | Cytarabine High Dose | null | null | VINBLASTINE | 101003263 |
| 240002018 | 240008358 | 1.67 | 91.6 | Curative (C) | 2016-09-24 | 2016-09-24 | AML MyeChild 01 Arm E MAC HSCT | 02 | N | IBRUTINIB | 100621522 |
| 240002028 | 240008360 | 1.75 | 55.8 | 03 | null | 2017-12-27 | Cytarabine High Dose | null | null | CLADRIBINE | 100853005 |
| 240002033 | 240008361 | 1.43 | 41.4 | Curative (C) | null | 2021-12-31 | AML Interim Guidelines FLAG-Ida | null | N | TRANSPLANT CARMUSTINE + THIOTEPA | 101812728 |
| 240002040 | 240008363 | null | null | Curative (C) | null | 2021-12-05 | IMATINIB | null | null | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 100607609 |
| 240002041 | 240008364 | 1.66 | 96.5 | null | 2021-01-28 | 2021-01-28 | Arsenic Triox + Tretinoin Ind W5-8 | 02 | null | ALL ALLR3: S/IR CONS | 100438538 |
| 240002049 | 240008367 | 1.7 | 30.6 | Not known (9) | null | 2017-10-16 | AML MyeChild 01 Triple IT | null | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 101637767 |
| 240002052 | 240008368 | 1.85 | 77.75 | Curative (C) | null | 2019-09-13 | Venetoclax | 02 | N | RUXOLITINIB | 101644714 |
| 240002060 | 240008372 | 1.76 | 80 | 03 | null | 2021-05-01 | GEMTUZUMAB OZOGAMICIN | null | N | FLAIR TRIAL | 101089272 |
| 240002070 | 240008375 | 1.67 | 17.3 | null | null | 2020-05-28 | CNS Low Grade Glioma Vinblastine | null | null | CLADRIBINE | 100340604 |
| 240002073 | 240008376 | 1.9 | 115 | 03 | null | 2020-03-28 | null | 01 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101499218 |
| 240002074 | 240008377 | 1.84 | 95 | Curative (C) | 2018-07-09 | 2018-07-10 | Dasatinib | 02 | N | CYTARABINE HIGH DOSE | 100410732 |
| 240002076 | 240008378 | 1.84 | 145 | Curative (C) | 2017-05-07 | 2017-05-15 | Cytarabine High Dose | N | null | RUXOLITINIB | 100182690 |
| 240002080 | 240008379 | 1.54 | 58.65 | Curative (C) | 2018-10-28 | 2019-02-21 | DHAX - R | N | null | ALL ALLR3: S/IR IND | 100955191 |
| 240002082 | 240008380 | 1.78 | 80.4 | null | 2020-05-11 | 2020-05-11 | Etoposide oral | 02 | null | IMATINIB | 100934477 |
| 240002093 | 240008382 | 1.84 | 0 | Curative (C) | 2016-02-05 | 2016-12-30 | null | N | null | AML MYECHILD 01 HD ARAC | 100488667 |
| 240002096 | 240008384 | 1.63 | 0 | null | null | 2020-08-11 | PEG INTERFERON | null | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101337720 |
| 240002106 | 240008386 | 1.62 | 0 | Palliative (P) | null | 2021-10-28 | Enzalutamide | null | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 100141805 |
| 240002109 | 240008387 | 1.81 | 53.9 | Palliative (P) | null | 2019-05-14 | AML Relapsed FLA | Y | N | CISPLATIN + GEMCITABINE | 100399769 |
| 240002116 | 240008390 | 1.67 | 94.4 | Palliative (P) | 2020-08-01 | 2020-08-03 | R GCVP | 02 | N | CYTARABINE HIGH DOSE | 100380209 |
| 240002119 | 240008391 | 1.67 | 77.75 | null | 2019-01-06 | 2019-04-01 | ALL UKALL2011 Ind A Std Dex (PAsp) | 02 | null | ANAGRELIDE | 101070652 |
| 240002123 | 240008393 | 1.59 | 0 | 03 | 2021-05-15 | 2021-05-15 | ALL UKALL2011 Maintenance A1 | 02 | N | CISPLATIN + GEMCITABINE | 101713967 |
| 240002129 | 240008394 | 1.6 | 47 | 03 | null | 2020-04-19 | DA 3+8 | null | N | BUSULFAN | 100862412 |
| 240002134 | 240008396 | null | null | Adjuvant (A) | null | 2021-08-20 | FLUOROURACIL + OXALIPLATIN | null | N | RUXOLITINIB | 100183450 |
| 240002136 | 240008397 | 1.59 | 18.8 | null | null | 2021-04-23 | null | N | null | CNS LOW GRADE GLIOMA VINBLASTINE | 101441200 |
| 240002168 | 240008409 | 1.02 | null | Curative (C) | null | 2018-01-21 | null | null | N | QUIZARTINIB | 100866746 |
| 240002169 | 240008410 | 1.72 | 78.5 | Adjuvant (A) | 2020-11-13 | 2020-11-16 | DACARBAZINE + DOXORUBICIN | 02 | N | AML MYECHILD 01 IT CYT | 100945623 |